Signature-Logo.png
TRxADE HEALTH, Inc. Announces Extension of Form 10-Q Filing
August 14, 2023 10:25 ET | Trxade Health, Inc.
TAMPA, FL, Aug. 14, 2023 (GLOBE NEWSWIRE) -- TRxADE HEALTH, Inc. (NASDAQ: MEDS) (“TRxADE”), a pharmaceutical exchange platform provider, today announced that it has filed for an extension to file...
Signature-Logo.png
Superlatus, Inc. and TRxADE HEALTH, Inc. Sign Definitive Merger Agreement to Create a Global Strategic Platform for Food and Healthy Snack Marketplace and Distribution
June 30, 2023 08:05 ET | Trxade Health, Inc.
NEW YORK, June 30, 2023 (GLOBE NEWSWIRE) -- Superlatus, Inc. (“Superlatus”), a U.S.-based holding company of food products and distribution capabilities, announced today that it has signed a...
Trxade_Corp_Logo.jpg
TRxADE Group Reports Record First Quarter 2021 Financial Results
April 26, 2021 16:05 ET | Trxade Group, Inc.
First Quarter Revenues Increased 39% to $3.1 Million TAMPA, FL, April 26, 2021 (GLOBE NEWSWIRE) -- Trxade Group, Inc. (NASDAQ: MEDS), a health services IT company focused on digitalizing the...
logo.jpg.png
Trxade Group Announces Addition to the Russell MicroCap Index
June 23, 2020 08:00 ET | Trxade Group, Inc.
Company Provides Reminder Regarding Tomorrow’s Scheduled Virtual Presentation TAMPA, FL, June 23, 2020 (GLOBE NEWSWIRE) -- Trxade Group, Inc. (NASDAQ: MEDS) an integrated drug procurement,...
logo.jpg.png
Trxade Group, Inc. Withdraws Its Previously Filed FDA Emergency Use Authorization for Rapid COVID-19 Testing Kit in Response To FDA Guidance
May 07, 2020 17:33 ET | Trxade Group, Inc.
TAMPA, FL, May 07, 2020 (GLOBE NEWSWIRE) -- Trxade Group, Inc. (NASDAQ: MEDS), an integrated drug procurement, delivery and healthcare platform, announced today that its wholly-owned subsidiary,...
logo.jpg.png
TRxADE Group Reports First Quarter 2020 Financial Results
May 04, 2020 08:00 ET | Trxade Group, Inc.
Q1 2020 Revenues Increase 46% to $2.2 Million; Drives Net Income Increase of 44% to $0.2 Million TAMPA, FL, May 04, 2020 (GLOBE NEWSWIRE) -- Trxade Group, Inc., (NASDAQ: MEDS) (“Trxade” or the...
logo.jpg.png
TRxADE GROUP, INC. Sets Date for 2020 Annual Meeting of Stockholders
April 02, 2020 16:15 ET | Trxade Group, Inc.
TAMPA, FL, April 02, 2020 (GLOBE NEWSWIRE) -- Trxade Group, Inc., (Nasdaq: MEDS)(“Trxade Group” or the “Company”), an integrated telehealth, drug procurement, delivery and healthcare platform that...
logo.jpg.png
TRxADE GROUP, INC. REPORTS 2019 RESULTS
March 30, 2020 08:05 ET | Trxade Group, Inc.
Delivered 2019 annual revenues of $7.43 Million (94.1% increase)Total Adjusted EBITDA of $852,647 (249% increase)Launched next generation of Telehealth Platform ( www.Bonumhealth.com ) Launched Drug...